Chagas disease is an anthropozoonosis from the American continent that has spread from
its original boundaries through migration. It is caused by the protozoan Trypanosoma cruzi …

A hundred years from its description, Chagas cardiomyopathy remains a challenging
disease. Although successful vector-control strategies have decreased the incidence of …

Chagas disease results from infection by the protozoan parasite Trypanosoma cruzi and is
endemic in Latin America. T cruzi is most commonly transmitted through the feces of an …

Background Prevention of chronic chagasic cardiomyopathy (CCC) by treating infected
populations with trypanocidal therapy (TT) remains a challenge. Despite a renewed …

Background—Peculiar aspects of Chagas cardiomyopathy raise concerns about efficacy
and safety of sympathetic blockade. We studied the influence of β-blockers in patients with …

Chagas disease, also known as American trypanosomiasis, results from infection by the
protozoan Trypanosoma cruzi, and is a major cause of cardiac disease worldwide. Until …

FUNDAMENTO: Pouco se sabe sobre o desfecho dos pacientes com cardiopatia chagásica,
em comparação aos pacientes com miocardiopatia dilatada idiopática na era …

Background Chagas cardiomyopathy (ChC) prevalence is decreasing in Brazil and medical
therapies for heart failure (HF) have improved in the last decade. Whether these changes …

Chagas cardiomyopathy is the most severe manifestation of human Chagas disease and
represents the major cause of morbidity and mortality in Latin America. We previously …

Heart failure (HF) studies typically focus on ischemic and idiopathic heart diseases. Chronic
chagasic cardiomyopathy (CCC) is a progressive degenerative inflammatory condition …